Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Establishing a Swedish-Danish Innovation Partnership for Translational Treg Therapeutics
| Reference number | 2026-01918 |
| Coordinator | Cellphi Biotechnology AB |
| Funding from Vinnova | SEK 422 908 |
| Project duration | October 2026 - March 2027 |
| Status | Ongoing |
| Venture | Preparation projects for international application within health |
| Call | Deepened international collaborations for healthy and resilient societies |
Last updated 25 September 2026
Reference number 2026-01918
